Wells Fargo & Company Glaukos Corp Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Glaukos Corp stock. As of the latest transaction made, Wells Fargo & Company holds 35,283 shares of GKOS stock, worth $3.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,283

Previous 32,512 8.52%

Holding current value

$3.58 Million

Previous $4.87 Million 28.76%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$96.6 - $161.22 $267,678 - $446,740	2,771 Added 8.52%	35,283 $3.47 Million
Q4 2024 Feb 12, 2025	BUY	$126.42 - $152.67 $934,496 - $1.13 Million	7,392 Added 29.43%	32,512 $4.87 Million
Q3 2024 Nov 13, 2024	BUY	$113.62 - $135.39 $89,873 - $107,093	791 Added 3.25%	25,120 $3.27 Million
Q2 2024 Aug 13, 2024	BUY	$89.48 - $118.35 $470,575 - $622,402	5,259 Added 27.58%	24,329 $2.88 Million
Q1 2024 May 10, 2024	BUY	$76.4 - $96.33 $45,840 - $57,798	600 Added 3.25%	19,070 $1.8 Million
Q4 2023 Feb 09, 2024	BUY	$59.53 - $85.11 $429,270 - $613,728	7,211 Added 64.05%	18,470 $1.47 Million
Q3 2023 Nov 13, 2023	SELL	$69.23 - $79.09 $874,859 - $999,460	-12,637 Reduced 52.88%	11,259 $847,000
Q2 2023 Aug 15, 2023	BUY	$45.44 - $71.21 $479,301 - $751,123	10,548 Added 79.02%	23,896 $1.7 Million
Q1 2023 May 12, 2023	BUY	$43.88 - $52.48 $371,224 - $443,980	8,460 Added 173.08%	13,348 $668,000
Q4 2022 Feb 13, 2023	SELL	$40.82 - $57.75 $90,416 - $127,916	-2,215 Reduced 31.18%	4,888 $213,000
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $54,521 - $68,082	-1,164 Reduced 14.08%	7,103 $378,000
Q2 2022 Aug 12, 2022	SELL	$34.86 - $63.77 $647,280 - $1.18 Million	-18,568 Reduced 69.19%	8,267 $375,000
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $8.25 Million - $10.8 Million	-186,145 Reduced 87.4%	26,835 $1.55 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $101,762 - $144,013	2,527 Added 1.2%	212,980 $9.46 Million
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $6 Million - $10.7 Million	126,573 Added 150.9%	210,453 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $689,905 - $922,581	9,443 Added 12.69%	83,880 $7.12 Million
Q1 2021 May 13, 2021	SELL	$70.43 - $97.42 $1.66 Million - $2.29 Million	-23,547 Reduced 24.03%	74,437 $6.25 Million
Q4 2020 Feb 09, 2021	SELL	$48.9 - $75.26 $4.29 Million - $6.59 Million	-87,628 Reduced 47.21%	97,984 $7.37 Million
Q3 2020 Nov 05, 2020	BUY	$37.23 - $50.97 $1.18 Million - $1.61 Million	31,597 Added 20.52%	185,612 $9.19 Million
Q2 2020 Aug 13, 2020	BUY	$28.78 - $46.83 $465,516 - $757,475	16,175 Added 11.73%	154,015 $5.92 Million
Q1 2020 May 14, 2020	BUY	$25.53 - $70.14 $3.52 Million - $9.67 Million	137,840 New	137,840 $4.25 Million

Others Institutions Holding GKOS

# of Institutions

358

Shares Held

50.2M

Call Options Held

260K

Put Options Held

776K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.83B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Glaukos Corp Transaction History